Solomon, Ahmed
Stanwix, Anne E.
Castañeda, Santos
Llorca, Javier
Gonzalez-Juanatey, Carlos
Hodkinson, Bridget
Romela, Benitha
Ally, Mahmood M. T. M.
Maharaj, Ajesh B.
Van Duuren, Elsa M.
Ziki, Joyce J.
Seboka, Mpoti
Mohapi, Makgotso
Jansen Van Rensburg, Barend J.
Tarr, Gareth S.
Makan, Kavita
Balton, Charlene
Gogakis, Aphrodite
González-Gay, Miguel A.
Dessein, Patrick H. https://orcid.org/0000-0002-9357-4630
Funding for this research was provided by:
The South African Arthritis and Rheumatism Association (Not applicable)
Article History
Received: 30 March 2020
Accepted: 7 May 2020
First Online: 16 June 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Miguel A Gonzalez-Gay received grants/research support from AbbVie, MSD, Janssen and Roche, and had consultation fees/participation in company sponsored speaker’s bureau from AbbVie, Pfizer, Roche, Sanofi, Celgene, Sobi and MSD. Santos Castañeda received grants/research support from MSD, Pfizer and Roche, and had consultation/honorary fees from Amgen, Celgene, Eli-Lilly, Sanofi, Sobi and UCB. Patrick H Dessein received a consultation/honorary fee from Janssen Pharmaceutica. Santos Castañeda is assistant professor of a chair supported by ROCHE at the Autonomous University of Madrid (UAM), Spain. The other co-authors declare that they have no declarations of interest.